Waiv
French tech company | Builders Republic
About
AI precision-oncology testing platform applying foundation models to digitized tissue slides — clinically deployed tests for breast cancer, colorectal cancer and immune-response markers, running on its Destra digital-pathology system to give labs, clinicians and pharma biomarker and treatment-response insights.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2024
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 29 M€ raised since 2020
Funding rounds
- Series A — 2026
Investors
- Alpha Intelligence Capital
- Karista
- OTB Ventures
- Serena
- Sistafund